EXTENDED BENCH

Live / Registered — Registered (as of 07 Jul 2026)

What this means for you

Registered since 07 Jul 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 07 Jul 2032: the §8 declaration of use).

Record

Serial number
99322680
Registration number
8331134
Mark type
Word mark
Filed
06 Aug 2025
Published for opposition
19 May 2026
Registered
07 Jul 2026
Next maintenance filing
§8 declaration of use, due by 07 Jul 2032 (grace period to 07 Jan 2033)
Attorney of record
Laura A. Kees

Goods and services

  • Class 001 — Chemicals: Chemicals for use in the pharmaceutical industry; active chemical ingredients for use in the manufacture of pharmaceuticals
  • Class 005 — Pharmaceuticals: Pharmaceuticals, namely, psychotropics, antihelmintics, anti-infectives, lipid lowering agents, inducers of erections, induction agents, neuromuscular blocking agents, sedatives, anti-cancer medication, anti-inflammatories, anti-fungals, anti-bacterials, anti-spasmodics, appetite stimulants, bronchodilators, appetite suppressants, anti-convulsives, neuroprotective drugs, anti-anxiety medication, anti-depressants, anti-ischemics, anti-psychotics; pharmaceutical preparations for treating diabetes, ear, nose and throat disorders, epilepsy, genetic disorders, hematological disorders, hormonal disorders, infectious diseases, lymphoma, metabolic disorders, mouth and dental disorders, musculoskeletal disorder, non-malignant disorder, nutritional disorders, pain, rare ophthalmological diseases, rare cancers, rare infectious diseases, rare genetic diseases, rare respiratory diseases, rare central nervous system diseases, rare gastrointestinal diseases, rare immunological diseases, rare cardiovascular diseases, rare dermatological diseases, rare urinary system and sex hormone diseases, rare womens health diseases, and rare ear, nose, and throat diseases; pharmaceuticals for medical or veterinary purposes, namely, pharmaceutical preparations and substances for the treatment of viral, infectious, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines; medicine for treating diabetes, ear, nose and throat disorders, epilepsy, genetic disorders, hematological disorders, hormonal disorders, infectious diseases, lymphoma, metabolic disorders, mouth and dental disorders, musculoskeletal disorder, non-malignant disorder, nutritional disorders, pain, rare ophthalmological diseases, rare cancers, rare infectious diseases, rare genetic diseases, rare respiratory diseases, rare central nervous system diseases, rare gastrointestinal diseases, rare immunological diseases, rare cardiovascular diseases, rare dermatological diseases, rare urinary system and sex hormone diseases, rare womens health diseases, and rare ear, nose, and throat diseases
  • Class 040 — Treatment of materials: Custom manufacturing in the field of pharmaceuticals; processing of pharmaceuticals; custom manufacture of pharmaceuticals; treatment of pharmaceuticals; treatment and disposal being destruction of pharmaceutical waste; information, advice and consultancy services in relation to the aforesaid services
  • Class 042 — Scientific and technological services: Pharmaceutical research services; pharmaceutical development services; pharmaceutical product design services; testing of pharmaceuticals; scientific research in the nature of conducting clinical trials for others relating to pharmaceuticals and chemicals; pharmaceutical analysis, namely, chemical composition analysis, testing, analysis, and evaluation of pharmaceuticals of others to determine conformity with certification standards; pharmaceutical laboratory research services relating to pharmaceuticals; pharmaceutical product evaluation; pharmaceutical reports, namely, preparation of reports relating to pharmaceutical research; inspection of pharmaceuticals; biological research services; quality control and authentication services for others in the field of pharmaceuticals; information, advice and consultancy services in relation to the aforesaid services

Owner

Prosecution history

  • 07 Jul 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 07 Jul 2026 — REGISTERED-PRINCIPAL REGISTER
  • 19 May 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 19 May 2026 — PUBLISHED FOR OPPOSITION
  • 13 May 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 24 Apr 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 24 Apr 2026 — EXAMINER'S AMENDMENT ENTERED
  • 24 Apr 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
  • 24 Apr 2026 — EXAMINERS AMENDMENT E-MAILED
  • 24 Apr 2026 — EXAMINERS AMENDMENT -WRITTEN
  • 09 Apr 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 09 Apr 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 09 Apr 2026 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
  • 23 Mar 2026 — NOTIFICATION OF FINAL REFUSAL EMAILED
  • 23 Mar 2026 — FINAL REFUSAL E-MAILED

View this trademark record on Rightsy